INS and Hyperglycemia: When IR occurs in the liver, the tyrosine phosphorylation of IRS1 is severely damaged by hyperglycemia, leading to a decrease in the liver’s ability to absorb glucose, affecting proximal defects in the INSR, IRS1, PI3K, and AKT pathways and impairing the insulin transduction pathway.